Day & Ennis’s AbbVie ABBV Stock Holding History

Day & Ennis’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	$3.02M	Buy	19,501 +24	+0.1%	+$3.72K	1.07%	22
2023 Q3	$2.9M	Sell	19,477 -183	-0.9%	-$27.3K	1.08%	24
2023 Q2	$2.65M	Buy	19,660 +381	+2%	+$51.3K	1.01%	24
2023 Q1	$3.07M	Buy	19,279 +270	+1%	+$43K	1.14%	23
2022 Q4	$3.07M	Sell	19,009 -130	-0.7%	-$21K	1.19%	22
2022 Q3	$2.57M	Buy	19,139 +83	+0.4%	+$11.1K	1.07%	30
2022 Q2	$2.92M	Buy	19,056 +614	+3%	+$94.1K	1.11%	30
2022 Q1	$2.99M	Buy	18,442 +21	+0.1%	+$3.41K	0.99%	33
2021 Q4	$2.49M	Buy	18,421 +280	+2%	+$37.9K	0.82%	37
2021 Q3	$1.96M	Buy	18,141 +442	+2%	+$47.7K	0.68%	45
2021 Q2	$1.99M	Buy	17,699 +1,298	+8%	+$146K	0.69%	43
2021 Q1	$1.78M	Buy	16,401 +271	+2%	+$29.3K	0.67%	42
2020 Q4	$1.73M	Buy	16,130 +955	+6%	+$102K	0.69%	44
2020 Q3	$1.33M	Buy	15,175 +1,032	+7%	+$90.4K	0.58%	46
2020 Q2	$1.39M	Buy	14,143 +373	+3%	+$36.6K	0.69%	46
2020 Q1	$1.05M	Buy	13,770 +140	+1%	+$10.7K	0.6%	43
2019 Q4	$1.21M	Buy	13,630 +1,048	+8%	+$92.8K	0.59%	38
2019 Q3	$953K	Buy	12,582 +2,450	+24%	+$186K	0.49%	41
2019 Q2	$737K	Buy	10,132 +2,671	+36%	+$194K	0.39%	50
2019 Q1	$601K	Sell	7,461 -232	-3%	-$18.7K	0.34%	50
2018 Q4	$709K	Sell	7,693 -61	-0.8%	-$5.62K	0.47%	48
2018 Q3	$733K	Buy	7,754 +61	+0.8%	+$5.77K	0.49%	46
2018 Q2	$713K	Buy	7,693 +84	+1%	+$7.79K	0.53%	45
2018 Q1	$720K	Buy	7,609 +75	+1%	+$7.1K	0.59%	42
2017 Q4	$729K	Buy	7,534 +200	+3%	+$19.4K	0.6%	40
2017 Q3	$652K	Sell	7,334 -3,114	-30%	-$277K	0.58%	40
2017 Q2	$758K	Buy	10,448 +226	+2%	+$16.4K	0.65%	40
2017 Q1	$666K	Sell	10,222 -1,366	-12%	-$89K	0.63%	33
2016 Q4	$726K	Buy	11,588 +430	+4%	+$26.9K	0.74%	28
2016 Q3	$704K	Buy	11,158 +209	+2%	+$13.2K	0.74%	27
2016 Q2	$678K	Hold	10,949	–	–	0.74%	28
2016 Q1	$625K	Buy	10,949 +575	+6%	+$32.8K	0.69%	28
2015 Q4	$615K	Buy	+10,374	New	+$615K	0.69%	27